<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36986528</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1424-8247</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>11</Day></PubDate></JournalIssue><Title>Pharmaceuticals (Basel, Switzerland)</Title><ISOAbbreviation>Pharmaceuticals (Basel)</ISOAbbreviation></Journal><ArticleTitle>Design, Synthesis, and Antiviral Activities of New Benzotriazole-Based Derivatives.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">429</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ph16030429</ELocationID><Abstract><AbstractText>Several human diseases are caused by enteroviruses and are currently clinically untreatable, pushing the research to identify new antivirals. A notable number of benzo[<i>d</i>][1,2,3]triazol-1(2)-yl derivatives were designed, synthesized, and in vitro evaluated for cytotoxicity and antiviral activity against a wide spectrum of RNA positive- and negative-sense viruses. Five of them (<b>11b</b>, <b>18e</b>, <b>41a</b>, <b>43a</b>, <b>99b</b>) emerged for their selective antiviral activity against Coxsackievirus B5, a human enteroviruses member among the <i>Picornaviridae</i> family. The EC<sub>50</sub> values ranged between 6 and 18.5 μM. Among all derivatives, compounds <b>18e</b> and <b>43a</b> were interestingly active against CVB5 and were selected to better define the safety profile on cell monolayers by transepithelial resistance test (TEER). Results indicated compound <b>18e</b> as the hit compound to investigate the potential mechanism of action by apoptosis assay, virucidal activity test, and the time of addition assay. CVB5 is known to be cytotoxic by inducing apoptosis in infected cells; in this study, compound <b>18e</b> was proved to protect cells from viral infection. Notably, cells were mostly protected when pre-treated with derivative <b>18e</b>, which had, however, no virucidal activity. From the performed biological assays, compound <b>18e</b> turned out to be non-cytotoxic as well as cell protective against CVB5 infection, with a mechanism of action ascribable to an interaction on the early phase of infection, by hijacking the viral attachment process.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ibba</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-3332-3845</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Pharmacy, University of Sassari, Via Muroni, 23/A, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corona</LastName><ForeName>Paola</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-9182-478X</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Pharmacy, University of Sassari, Via Muroni, 23/A, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nonne</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>GSK Vaccine Institute for Global Health GSK, Via Fiorentina, 1, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caria</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Section of Microbiology and Virology, University of Cagliari, Cittadella Universitaria, 09042 Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serreli</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-1971-3989</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Section of Microbiology and Virology, University of Cagliari, Cittadella Universitaria, 09042 Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palmas</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Section of Microbiology and Virology, University of Cagliari, Cittadella Universitaria, 09042 Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riu</LastName><ForeName>Federico</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-2645-3097</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Pharmacy, University of Sassari, Via Muroni, 23/A, 07100 Sassari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry, Biomedicinskt Centrum, BMC, Uppsala University, Box 576, 75123 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sestito</LastName><ForeName>Simona</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6173-525X</Identifier><AffiliationInfo><Affiliation>Department of Chemical, Physical, Mathematical and Natural Sciences, University of Sassari, Via Vienna 2, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieddu</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7589-0464</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Pharmacy, University of Sassari, Via Muroni, 23/A, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loddo</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Section of Microbiology and Virology, University of Cagliari, Cittadella Universitaria, 09042 Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanna</LastName><ForeName>Giuseppina</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-3999-4263</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Section of Microbiology and Virology, University of Cagliari, Cittadella Universitaria, 09042 Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piras</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Pharmacy, University of Sassari, Via Muroni, 23/A, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carta</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Pharmacy, University of Sassari, Via Muroni, 23/A, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>FAR2020Piras</GrantID><Agency>University of Sassari</Agency><Country /></Grant><Grant><GrantID>FAR2020Corona</GrantID><Agency>University of Sassari</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pharmaceuticals (Basel)</MedlineTA><NlmUniqueID>101238453</NlmUniqueID><ISSNLinking>1424-8247</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Picornaviridae</Keyword><Keyword MajorTopicYN="N">RNA-virus</Keyword><Keyword MajorTopicYN="N">antiviral compounds</Keyword><Keyword MajorTopicYN="N">benzotriazoles</Keyword><Keyword MajorTopicYN="N">coxsackievirus B5</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>2</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36986528</ArticleId><ArticleId IdType="pmc">PMC10054465</ArticleId><ArticleId IdType="doi">10.3390/ph16030429</ArticleId><ArticleId IdType="pii">ph16030429</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Johnson N.P.A.S., Mueller J. Updating the Accounts: Global Mortality of the 1918-1920 “Spanish” Influenza Pandemic. Bull. Hist. Med. 2002;76:105–115. doi: 10.1353/bhm.2002.0022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1353/bhm.2002.0022</ArticleId><ArticleId IdType="pubmed">11875246</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajagopal S., Treanor J. Pandemic (Avian) Influenza. Semin. Respir. Crit. Care Med. 2007;28:159–170. doi: 10.1055/s-2007-976488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2007-976488</ArticleId><ArticleId IdType="pubmed">17458770</ArticleId></ArticleIdList></Reference><Reference><Citation>Viboud C., Simonsen L., Fuentes R., Flores J., Miller M.A., Chowell G. Global Mortality Impact of the 1957–1959 Influenza Pandemic. J. Infect. Dis. 2016;213:738–745. doi: 10.1093/infdis/jiv534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiv534</ArticleId><ArticleId IdType="pmc">PMC4747626</ArticleId><ArticleId IdType="pubmed">26908781</ArticleId></ArticleIdList></Reference><Reference><Citation>1968 Pandemic (H3N2 Virus)|Pandemic Influenza (Flu)|CDC.  [(accessed on 13 January 2023)]; Available online:  https://www.cdc.gov/flu/pandemic-resources/1968-pandemic.html.</Citation></Reference><Reference><Citation>Global HIV Programme.  [(accessed on 13 January 2023)].  Available online:  https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/strategic-information/hiv-data-and-statistics.</Citation></Reference><Reference><Citation>Ruan L., Zeng G. Emerging Infections in Asia. Springer US; Boston, MA, USA: 2008. SARS Epidemic: SARS Outbreaks in Inner-Land of China; pp. 75–96.</Citation></Reference><Reference><Citation>CDC Novel H1N1 Flu|The 2009 H1N1 Pandemic: Summary Highlights, April 2009–April 2010.  [(accessed on 13 January 2023)]; Available online:  https://www.cdc.gov/h1n1flu/cdcresponse.htm.</Citation></Reference><Reference><Citation>de Wit E., van Doremalen N., Falzarano D., Munster V.J. SARS and MERS: Recent Insights into Emerging Coronaviruses. Nat. Rev. Microbiol. 2016;14:523–534. doi: 10.1038/nrmicro.2016.81.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2016.81</ArticleId><ArticleId IdType="pmc">PMC7097822</ArticleId><ArticleId IdType="pubmed">27344959</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E.C., Dudas G., Rambaut A., Andersen K.G. The Evolution of Ebola Virus: Insights from the 2013–2016 Epidemic. Nature. 2016;538:193–200. doi: 10.1038/nature19790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature19790</ArticleId><ArticleId IdType="pmc">PMC5580494</ArticleId><ArticleId IdType="pubmed">27734858</ArticleId></ArticleIdList></Reference><Reference><Citation>Adil M.T., Rahman R., Whitelaw D., Jain V., Al-Taan O., Rashid F., Munasinghe A., Jambulingam P. SARS-CoV-2 and the Pandemic of COVID-19. Postgrad. Med. J. 2021;97:110–116. doi: 10.1136/postgradmedj-2020-138386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2020-138386</ArticleId><ArticleId IdType="pmc">PMC10016996</ArticleId><ArticleId IdType="pubmed">32788312</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray C.J.L., Ortblad K.F., Guinovart C., Lim S.S., Wolock T.M., Roberts D.A., Dansereau E.A., Graetz N., Barber R.M., Brown J.C., et al. Global, Regional, and National Incidence and Mortality for HIV, Tuberculosis, and Malaria during 1990–2013: A Systematic Analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:1005–1070. doi: 10.1016/S0140-6736(14)60844-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60844-8</ArticleId><ArticleId IdType="pmc">PMC4202387</ArticleId><ArticleId IdType="pubmed">25059949</ArticleId></ArticleIdList></Reference><Reference><Citation>Kujawski S.A., Midgley C.M., Rha B., Lively J.Y., Nix W.A., Curns A.T., Payne D.C., Englund J.A., Boom J.A., Williams J.V., et al. Enterovirus D68–Associated Acute Respiratory Illness—New Vaccine Surveillance Network, United States, July–October, 2017 and 2018. MMWR Morb. Mortal Wkly. Rep. 2019;68:277–280. doi: 10.15585/mmwr.mm6812a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6812a1</ArticleId><ArticleId IdType="pmc">PMC6448985</ArticleId><ArticleId IdType="pubmed">30921299</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K., Asturias E.J., Hixon A.M., van Leer-Buter C., Niesters H.G.M., Tyler K.L., Abzug M.J., Dominguez S.R. Enterovirus D68 and Acute Flaccid Myelitis—Evaluating the Evidence for Causality. Lancet Infect. Dis. 2018;18:e239–e247. doi: 10.1016/S1473-3099(18)30094-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(18)30094-X</ArticleId><ArticleId IdType="pmc">PMC6778404</ArticleId><ArticleId IdType="pubmed">29482893</ArticleId></ArticleIdList></Reference><Reference><Citation>Greninger A.L., Naccache S.N., Messacar K., Clayton A., Yu G., Somasekar S., Federman S., Stryke D., Anderson C., Yagi S., et al. A Novel Outbreak Enterovirus D68 Strain Associated with Acute Flaccid Myelitis Cases in the USA (2012–14): A Retrospective Cohort Study. Lancet Infect. Dis. 2015;15:671–682. doi: 10.1016/S1473-3099(15)70093-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(15)70093-9</ArticleId><ArticleId IdType="pmc">PMC6027625</ArticleId><ArticleId IdType="pubmed">25837569</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Wang H., Tang J., He Y., Xiong T., Li W., Qu Y., Mu D. Clinical Characteristics of Severe Neonatal Enterovirus Infection: A Systematic Review. BMC Pediatr. 2021;21:127. doi: 10.1186/s12887-021-02599-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12887-021-02599-y</ArticleId><ArticleId IdType="pmc">PMC7958388</ArticleId><ArticleId IdType="pubmed">33722228</ArticleId></ArticleIdList></Reference><Reference><Citation>Smuts H., Cronje S., Thomas J., Brink D., Korsman S., Hardie D. Molecular Characterization of an Outbreak of Enterovirus-Associated Meningitis in Mossel Bay, South Africa, December 2015–January 2016. BMC. Infect. Dis. 2018;18:709. doi: 10.1186/s12879-018-3641-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-018-3641-4</ArticleId><ArticleId IdType="pmc">PMC6311073</ArticleId><ArticleId IdType="pubmed">30594238</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.H.P., Chong Y.M., Tay C.G., Koh M.T., Chem Y.K., Noordin N., Jahis R., Sam I.C., Chan Y.F. Detection of Enteroviruses during a 2018 Hand, Foot and Mouth Disease Outbreak in Malaysia. Trop. Biomed. 2021;38:150–153. doi: 10.47665/tb.38.1.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.47665/tb.38.1.026</ArticleId><ArticleId IdType="pubmed">33797539</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K., Abzug M.J., Dominguez S.R. 2014 Outbreak of Enterovirus D68 in North America. J. Med. Virol. 2016;88:739–745. doi: 10.1002/jmv.24410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24410</ArticleId><ArticleId IdType="pubmed">26489019</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahrs C.R., Chuda K., Tapia G., Stene L.C., Mårild K., Rasmussen T., Rønningen K.S., Lundin K.E.A., Kramna L., Cinek O., et al. Enterovirus as Trigger of Coeliac Disease: Nested Case-Control Study within Prospective Birth Cohort. BMJ. 2019;364:l231. doi: 10.1136/bmj.l231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l231</ArticleId><ArticleId IdType="pmc">PMC6372922</ArticleId><ArticleId IdType="pubmed">30760441</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez Bergamin C., Atala Dib S. Enterovirus and Type 1 Diabetes: What Is the Matter? World J. Diabetes. 2015;6:828. doi: 10.4239/wjd.v6.i6.828.</Citation><ArticleIdList><ArticleId IdType="doi">10.4239/wjd.v6.i6.828</ArticleId><ArticleId IdType="pmc">PMC4478578</ArticleId><ArticleId IdType="pubmed">26131324</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirand A., le Sage F.V., Pereira B., Cohen R., Levy C., Archimbaud C., Peigue-Lafeuille H., Bailly J.-L., Henquell C. Ambulatory Pediatric Surveillance of Hand, Foot and Mouth Disease as Signal of an Outbreak of Coxsackievirus A6 Infections, France, 2014–2015. Emerg. Infect. Dis. 2016;22:1884–1893. doi: 10.3201/eid2211.160590.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2211.160590</ArticleId><ArticleId IdType="pmc">PMC5088007</ArticleId><ArticleId IdType="pubmed">27767012</ArticleId></ArticleIdList></Reference><Reference><Citation>Keeren K., Böttcher S., Diedrich S. Enterovirus Surveillance (EVSurv) in Germany. Microorganisms. 2021;9:2005. doi: 10.3390/microorganisms9102005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9102005</ArticleId><ArticleId IdType="pmc">PMC8538599</ArticleId><ArticleId IdType="pubmed">34683328</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamau E., Nguyen D., Celma C., Blomqvist S., Horby P., Simmonds P., Harvala H. Seroprevalence and Virologic Surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006–2017. Emerg. Infect. Dis. 2021;27:2261–2268. doi: 10.3201/eid2709.204915.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2709.204915</ArticleId><ArticleId IdType="pmc">PMC8386771</ArticleId><ArticleId IdType="pubmed">34423767</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi E.-J., Shin Y.-J., Kim J.-H., Kim T.-G., Chang S.-Y. Enterovirus 71 Infection and Vaccines. Clin. Exp. Vaccine. Res. 2017;6:4. doi: 10.7774/cevr.2017.6.1.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.7774/cevr.2017.6.1.4</ArticleId><ArticleId IdType="pmc">PMC5292356</ArticleId><ArticleId IdType="pubmed">28168168</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikonov O.S., Chernykh E.S., Garber M.B., Nikonova E.Y. Enteroviruses: Classification, Diseases They Cause, and Approaches to Development of Antiviral Drugs. Biochemistry. 2017;82:1615–1631. doi: 10.1134/S0006297917130041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297917130041</ArticleId><ArticleId IdType="pmc">PMC7087576</ArticleId><ArticleId IdType="pubmed">29523062</ArticleId></ArticleIdList></Reference><Reference><Citation>Pevear D.C., Tull T.M., Seipel M.E., Groarke J.M. Activity of Pleconaril against Enteroviruses. Antimicrob. Agents Chemother. 1999;43:2109–2115. doi: 10.1128/AAC.43.9.2109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.43.9.2109</ArticleId><ArticleId IdType="pmc">PMC89431</ArticleId><ArticleId IdType="pubmed">10471549</ArticleId></ArticleIdList></Reference><Reference><Citation>Egorova A., Ekins S., Schmidtke M., Makarov V. Back to the Future: Advances in Development of Broad-Spectrum Capsid-Binding Inhibitors of Enteroviruses. Eur. J. Med. Chem. 2019;178:606–622. doi: 10.1016/j.ejmech.2019.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2019.06.008</ArticleId><ArticleId IdType="pmc">PMC8194503</ArticleId><ArticleId IdType="pubmed">31226653</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitaku E., Smith D.T., Njardarson J.T. Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals. J. Med. Chem. 2014;57:10257–10274. doi: 10.1021/jm501100b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm501100b</ArticleId><ArticleId IdType="pubmed">25255204</ArticleId></ArticleIdList></Reference><Reference><Citation>Labbozzetta M., Barreca M., Spanò V., Raimondi M.V., Poma P., Notarbartolo M., Barraja P., Montalbano A. Novel Insights on [1,2]Oxazolo[5,4- e ]Isoindoles on Multidrug Resistant Acute Myeloid Leukemia Cell Line. Drug Dev. Res. 2022;83:1331–1341. doi: 10.1002/ddr.21962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ddr.21962</ArticleId><ArticleId IdType="pmc">PMC9540667</ArticleId><ArticleId IdType="pubmed">35749723</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerru N., Gummidi L., Maddila S., Gangu K.K., Jonnalagadda S.B. A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications. Molecules. 2020;25:1909. doi: 10.3390/molecules25081909.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25081909</ArticleId><ArticleId IdType="pmc">PMC7221918</ArticleId><ArticleId IdType="pubmed">32326131</ArticleId></ArticleIdList></Reference><Reference><Citation>Cisar J.S., Pietsch C., DeRatt L.G., Jacoby E., Kazmi F., Keohane C., Legenski K., Matico R., Shaffer P., Simonnet Y., et al. N-Heterocyclic 3-Pyridyl Carboxamide Inhibitors of DHODH for the Treatment of Acute Myelogenous Leukemia. J. Med. Chem. 2022;65:11241–11256. doi: 10.1021/acs.jmedchem.2c00788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.2c00788</ArticleId><ArticleId IdType="pubmed">35925768</ArticleId></ArticleIdList></Reference><Reference><Citation>Cilibrasi V., Spanò V., Bortolozzi R., Barreca M., Raimondi M.V., Rocca R., Maruca A., Montalbano A., Alcaro S., Ronca R., et al. Synthesis of 2H-Imidazo[2′,1’:2,3] [1,3]Thiazolo[4,5-e]Isoindol-8-Yl-Phenylureas with Promising Therapeutic Features for the Treatment of Acute Myeloid Leukemia (AML) with FLT3/ITD Mutations. Eur. J. Med. Chem. 2022;235:114292. doi: 10.1016/j.ejmech.2022.114292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2022.114292</ArticleId><ArticleId IdType="pubmed">35339838</ArticleId></ArticleIdList></Reference><Reference><Citation>Corona P., Ibba R., Piras S., Molicotti P., Bua A., Carta A. Quinoxaline-based Efflux Pump Inhibitors Restore Drug Susceptibility in Drug-resistant Nontuberculous Mycobacteria. Arch. Pharm. 2022;355:2100492. doi: 10.1002/ardp.202100492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ardp.202100492</ArticleId><ArticleId IdType="pubmed">35532283</ArticleId></ArticleIdList></Reference><Reference><Citation>Madeddu S., Ibba R., Sanna G., Piras S., Riu F., Marongiu A., Ambrosino A., Caria P., Onnis V., Franci G., et al. Human Enterovirus B: Selective Inhibition by Quinoxaline Derivatives and Bioinformatic RNA-Motif Identification as New Targets. Pharmaceuticals. 2022;15:181. doi: 10.3390/ph15020181.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph15020181</ArticleId><ArticleId IdType="pmc">PMC8878107</ArticleId><ArticleId IdType="pubmed">35215294</ArticleId></ArticleIdList></Reference><Reference><Citation>Perera N., Brun J., Alonzi D.S., Tyrrell B.E., Miller J.L., Zitzmann N. Antiviral Effects of Deoxynojirimycin (DNJ)-Based Iminosugars in Dengue Virus-Infected Primary Dendritic Cells. Antiviral. Res. 2022;199:105269. doi: 10.1016/j.antiviral.2022.105269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2022.105269</ArticleId><ArticleId IdType="pmc">PMC9760573</ArticleId><ArticleId IdType="pubmed">35227758</ArticleId></ArticleIdList></Reference><Reference><Citation>Barreca M., Ingarra A.M., Raimondi M.V., Spanò V., de Franco M., Menilli L., Gandin V., Miolo G., Barraja P., Montalbano A. Insight on Pyrimido[5,4-g]Indolizine and Pyrimido[4,5-c]Pyrrolo[1,2-a]Azepine Systems as Promising Photosensitizers on Malignant Cells. Eur. J. Med. Chem. 2022;237:114399. doi: 10.1016/j.ejmech.2022.114399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2022.114399</ArticleId><ArticleId IdType="pubmed">35468516</ArticleId></ArticleIdList></Reference><Reference><Citation>Barreca M., Spanò V., Rocca R., Bivacqua R., Abel A.-C., Maruca A., Montalbano A., Raimondi M.V., Tarantelli C., Gaudio E., et al. Development of [1,2]Oxazoloisoindoles Tubulin Polymerization Inhibitors: Further Chemical Modifications and Potential Therapeutic Effects against Lymphomas. Eur. J. Med. Chem. 2022;243:114744. doi: 10.1016/j.ejmech.2022.114744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2022.114744</ArticleId><ArticleId IdType="pubmed">36242921</ArticleId></ArticleIdList></Reference><Reference><Citation>Briguglio I., Piras S., Corona P., Gavini E., Nieddu M., Boatto G., Carta A. Benzotriazole: An Overview on Its Versatile Biological Behavior. Eur. J. Med. Chem. 2015;97:612–648. doi: 10.1016/j.ejmech.2014.09.089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2014.09.089</ArticleId><ArticleId IdType="pmc">PMC7115563</ArticleId><ArticleId IdType="pubmed">25293580</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H.-Z., Gan L.-L., Wang H., Zhou C.-H. New Progress in Azole Compounds as Antimicrobial Agents. Mini-Rev. Med. Chem. 2016;17:122–166. doi: 10.2174/1389557516666160630120725.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389557516666160630120725</ArticleId><ArticleId IdType="pubmed">27484625</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelemen H., Orgovan G., Szekely-Szentmiklosi B. The Pharmaceutical Chemistry of Azole Antifungals. Acta Pharm. Hung. 2016;86:85–98.</Citation><ArticleIdList><ArticleId IdType="pubmed">29489080</ArticleId></ArticleIdList></Reference><Reference><Citation>Carta A., Palomba M., Briguglio I., Corona P., Piras S., Jabes D., Guglierame P., Molicotti P., Zanetti S. Synthesis and Anti-Mycobacterial Activities of Triazoloquinolones. Eur. J. Med. Chem. 2011;46:320–326. doi: 10.1016/j.ejmech.2010.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2010.11.020</ArticleId><ArticleId IdType="pubmed">21145625</ArticleId></ArticleIdList></Reference><Reference><Citation>Carta A., Bua A., Corona P., Piras S., Briguglio I., Molicotti P., Zanetti S., Laurini E., Aulic S., Fermeglia M., et al. Design, Synthesis and Antitubercular Activity of 4-Alkoxy-Triazoloquinolones Able to Inhibit the M. Tuberculosis DNA Gyrase. Eur. J. Med. Chem. 2019;161:399–415. doi: 10.1016/j.ejmech.2018.10.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2018.10.031</ArticleId><ArticleId IdType="pubmed">30384044</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibba R., Piras S., Corona P., Riu F., Loddo R., Delogu I., Collu G., Sanna G., Caria P., Dettori T., et al. Synthesis, Antitumor and Antiviral In Vitro Activities of New Benzotriazole-Dicarboxamide Derivatives. Front. Chem. 2021;9:660424. doi: 10.3389/fchem.2021.660424.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fchem.2021.660424</ArticleId><ArticleId IdType="pmc">PMC8129498</ArticleId><ArticleId IdType="pubmed">34017818</ArticleId></ArticleIdList></Reference><Reference><Citation>Riu F., Sanna L., Ibba R., Piras S., Bordoni V., Scorciapino M.A., Lai M., Sestito S., Bagella L., Carta A. A Comprehensive Assessment of a New Series of 5′,6′-Difluorobenzotriazole-Acrylonitrile Derivatives as Microtubule Targeting Agents (MTAs) Eur. J. Med. Chem. 2021;222:113590. doi: 10.1016/j.ejmech.2021.113590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2021.113590</ArticleId><ArticleId IdType="pubmed">34139625</ArticleId></ArticleIdList></Reference><Reference><Citation>Riu F., Ibba R., Zoroddu S., Sestito S., Lai M., Piras S., Sanna L., Bordoni V., Bagella L., Carta A. Design, Synthesis, and Biological Screening of a Series of 4′-Fluoro-Benzotriazole-Acrylonitrile Derivatives as Microtubule-Destabilising Agents (MDAs) J. Enzyme. Inhib. Med. Chem. 2022;37:2223–2240. doi: 10.1080/14756366.2022.2111680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14756366.2022.2111680</ArticleId><ArticleId IdType="pmc">PMC9397482</ArticleId><ArticleId IdType="pubmed">35979600</ArticleId></ArticleIdList></Reference><Reference><Citation>Loddo R., Novelli F., Sparatore A., Tasso B., Tonelli M., Boido V., Sparatore F., Collu G., Delogu I., Giliberti G., et al. Antiviral Activity of Benzotriazole Derivatives. 5-[4-(Benzotriazol-2-Yl)Phenoxy]-2,2-Dimethylpentanoic Acids Potently and Selectively Inhibit Coxsackie Virus B5. Bioorg. Med. Chem. 2015;23:7024–7034. doi: 10.1016/j.bmc.2015.09.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2015.09.035</ArticleId><ArticleId IdType="pubmed">26443549</ArticleId></ArticleIdList></Reference><Reference><Citation>Plewe M.B., Gantla V.R., Sokolova N.v., Shin Y.-J., Naik S., Brown E.R., Fetsko A., Zhang L., Kalveram B., Freiberg A.N., et al. Discovery of a Novel Highly Potent Broad-Spectrum Heterocyclic Chemical Series of Arenavirus Cell Entry Inhibitors. Bioorg. Med. Chem. Lett. 2021;41:127983. doi: 10.1016/j.bmcl.2021.127983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2021.127983</ArticleId><ArticleId IdType="pmc">PMC10187606</ArticleId><ArticleId IdType="pubmed">33965007</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu K.-L., Zhang Y., Civiello R.L., Kadow K.F., Cianci C., Krystal M., Meanwell N.A. Fundamental Structure–Activity Relationships Associated with a New Structural Class of Respiratory Syncytial Virus Inhibitor. Bioorg. Med. Chem. Lett. 2003;13:2141–2144. doi: 10.1016/S0960-894X(03)00383-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-894X(03)00383-4</ArticleId><ArticleId IdType="pubmed">12798322</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibba R., Carta A., Madeddu S., Caria P., Serreli G., Piras S., Sestito S., Loddo R., Sanna G. Inhibition of Enterovirus A71 by a Novel 2-Phenyl-Benzimidazole Derivative. Viruses. 2021;13:58. doi: 10.3390/v13010058.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13010058</ArticleId><ArticleId IdType="pmc">PMC7823780</ArticleId><ArticleId IdType="pubmed">33406781</ArticleId></ArticleIdList></Reference><Reference><Citation>Bivacqua R., Barreca M., Spanò V., Raimondi M.V., Romeo I., Alcaro S., Andrei G., Barraja P., Montalbano A. Insight into Non-Nucleoside Triazole-Based Systems as Viral Polymerases Inhibitors. Eur. J. Med. Chem. 2023;249:115136. doi: 10.1016/j.ejmech.2023.115136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2023.115136</ArticleId><ArticleId IdType="pubmed">36708678</ArticleId></ArticleIdList></Reference><Reference><Citation>Corona P., Piras S., Ibba R., Riu F., Murineddu G., Sanna G., Madeddu S., Delogu I., Loddo R., Carta A. Antiviral Activity of Benzotriazole Based Derivatives. Open Med. Chem. J. 2020;14:83–98. doi: 10.2174/1874104502014010083.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874104502014010083</ArticleId><ArticleId IdType="pubmed">31878859</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanna G., Piras S., Madeddu S., Busonera B., Klempa B., Corona P., Ibba R., Murineddu G., Carta A., Loddo R. 5,6-Dichloro-2-Phenyl-Benzotriazoles: New Potent Inhibitors of Orthohantavirus. Viruses. 2020;12:122. doi: 10.3390/v12010122.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12010122</ArticleId><ArticleId IdType="pmc">PMC7019903</ArticleId><ArticleId IdType="pubmed">31968537</ArticleId></ArticleIdList></Reference><Reference><Citation>Piras S., Corona P., Ibba R., Riu F., Murineddu G., Sanna G., Madeddu S., Delogu I., Loddo R., Carta A. Preliminary Anti-Coxsackie Activity of Novel 1-[4-(5,6-Dimethyl(H)-1H(2H)-Benzotriazol-1(2)-Yl)Phenyl]-3-Alkyl(Aryl)Ureas. Med. Chem. 2019;16:677–688. doi: 10.2174/1573406416666191226142744.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573406416666191226142744</ArticleId><ArticleId IdType="pubmed">31878859</ArticleId></ArticleIdList></Reference><Reference><Citation>Piras S., Sanna G., Carta A., Corona P., Ibba R., Loddo R., Madeddu S., Caria P., Aulic S., Laurini E., et al. Dichloro-Phenyl-Benzotriazoles: A New Selective Class of Human Respiratory Syncytial Virus Entry Inhibitors. Front. Chem. 2019;7:247. doi: 10.3389/fchem.2019.00247.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fchem.2019.00247</ArticleId><ArticleId IdType="pmc">PMC6476926</ArticleId><ArticleId IdType="pubmed">31041309</ArticleId></ArticleIdList></Reference><Reference><Citation>Carta A., Loriga M., Piras S., Paglietti G., Ferrone M., Fermeglia M., Pricl S., Colla P., Collu G., Sanna T., et al. Synthesis and Anti-Picornaviridae In Vitro Activity of a New Class of Helicase Inhibitors the N,N-Bis[4-(1H(2H)-Benzotriazol-1(2)-Yl)Phenyl] Alkyldicarboxamides. Med. Chem. 2007;3:520–532. doi: 10.2174/157340607782360308.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/157340607782360308</ArticleId><ArticleId IdType="pubmed">18045201</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirk K.L., Cohen L.A. Synthesis of Some Fluoronitrobenzimidazoles and Their Reactivities toward Peptide Nucleophiles. J. Org. Chem. 1969;34:384–389. doi: 10.1021/jo01254a027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jo01254a027</ArticleId><ArticleId IdType="pubmed">5786166</ArticleId></ArticleIdList></Reference><Reference><Citation>Liedholm B Copper (I) Catalysed Replacement of Bromine by Chloride Ion in Halonitrobenzenes. Part II. Acta Chem. Scand. 1971;25:106–112.</Citation></Reference><Reference><Citation>Sanna G., Madeddu S., Giliberti G., Piras S., Struga M., Wrzosek M., Kubiak-Tomaszewska G., Koziol A., Savchenko O., Lis T., et al. Synthesis and Biological Evaluation of Novel Indole-Derived Thioureas. Molecules. 2018;23:2554. doi: 10.3390/molecules23102554.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules23102554</ArticleId><ArticleId IdType="pmc">PMC6222422</ArticleId><ArticleId IdType="pubmed">30301264</ArticleId></ArticleIdList></Reference><Reference><Citation>Deiana M., Montoro P., Jerković I., Atzeri A., Marijanović Z., Serreli G., Piacente S., Tuberoso C.I.G. First Characterization of Pompia Intrea Candied Fruit: The Headspace Chemical Profile, Polar Extract Composition and Its Biological Activities. Food Res. Int. 2019;120:620–630. doi: 10.1016/j.foodres.2018.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodres.2018.11.016</ArticleId><ArticleId IdType="pubmed">31000280</ArticleId></ArticleIdList></Reference><Reference><Citation>Serreli G., Melis M.P., Zodio S., Naitza M.R., Casula E., Peñalver P., Lucas R., Loi R., Morales J.C., Deiana M. Altered Paracellular Permeability in Intestinal Cell Monolayer Challenged with Lipopolysaccharide: Modulatory Effects of Pterostilbene Metabolites. Food Chem. Toxicol. 2020;145:111729. doi: 10.1016/j.fct.2020.111729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2020.111729</ArticleId><ArticleId IdType="pubmed">32898597</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanna G., Farci P., Busonera B., Murgia G., la Colla P., Giliberti G. Antiviral Properties from Plants of the Mediterranean Flora. Nat. Prod. Res. 2015;29:2065–2070. doi: 10.1080/14786419.2014.1003187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14786419.2014.1003187</ArticleId><ArticleId IdType="pubmed">25613403</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>